134 related articles for article (PubMed ID: 20412595)
1. Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD.
Aaron SD; Vandemheen KL; Ramsay T; Zhang C; Avnur Z; Nikolcheva T; Quinn A
Respir Res; 2010 Apr; 11(1):41. PubMed ID: 20412595
[TBL] [Abstract][Full Text] [Related]
2. Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.
Ishikawa N; Hattori N; Kohno N; Kobayashi A; Hayamizu T; Johnson M
Int J Chron Obstruct Pulmon Dis; 2015; 10():185-92. PubMed ID: 25670894
[TBL] [Abstract][Full Text] [Related]
3. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.
Tangedal S; Aanerud M; Persson LJ; Brokstad KA; Bakke PS; Eagan TM
Respir Res; 2014 Nov; 15(1):138. PubMed ID: 25398249
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD.
Csoma B; Bikov A; Nagy L; Tóth B; Tábi T; Szűcs G; Komlósi ZI; Müller V; Losonczy G; Lázár Z
Respir Res; 2019 Jul; 20(1):156. PubMed ID: 31311549
[TBL] [Abstract][Full Text] [Related]
5. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
Bade G; Khan MA; Srivastava AK; Khare P; Solaiappan KK; Guleria R; Palaniyar N; Talwar A
Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975
[TBL] [Abstract][Full Text] [Related]
7. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study.
Singh D; Edwards L; Tal-Singer R; Rennard S
Respir Res; 2010 Jun; 11(1):77. PubMed ID: 20550701
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory biomarkers in sputum predict COPD exacerbations.
Tufvesson E; Ekberg M; Bjermer L
Lung; 2013 Aug; 191(4):413-6. PubMed ID: 23689877
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD.
Budulac SE; Postma DS; Hiemstra PS; Kunz LI; Siedlinski M; Smit HA; Vonk JM; Rutgers B; Timens W; Boezen HM;
Respir Res; 2010 May; 11(1):60. PubMed ID: 20487524
[TBL] [Abstract][Full Text] [Related]
10. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability.
Sapey E; Bayley D; Ahmad A; Newbold P; Snell N; Stockley RA
Thorax; 2008 Jun; 63(6):493-9. PubMed ID: 18057097
[TBL] [Abstract][Full Text] [Related]
11. Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD.
Beeh KM; Beier J; Kornmann O; Mander A; Buhl R
Chest; 2003 Mar; 123(3):778-83. PubMed ID: 12628878
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of fluid-phase measurements in PBS-treated sputum supernatant of healthy and stable COPD subjects.
Wang F; Liang Z; Yang Y; Zhou L; Guan L; Wu W; Jiang M; Shi W; Deng K; Chen J; Chen R
Int J Chron Obstruct Pulmon Dis; 2019; 14():835-852. PubMed ID: 31043775
[TBL] [Abstract][Full Text] [Related]
13. Variability of sputum inflammatory mediators in COPD and α1-antitrypsin deficiency.
Stone H; McNab G; Wood AM; Stockley RA; Sapey E
Eur Respir J; 2012 Sep; 40(3):561-9. PubMed ID: 22700846
[TBL] [Abstract][Full Text] [Related]
14. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
15. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
Kolsum U; Roy K; Starkey C; Borrill Z; Truman N; Vestbo J; Singh D
Int J Chron Obstruct Pulmon Dis; 2009; 4():149-56. PubMed ID: 19436686
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
17. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.
Garcia-Rio F; Miravitlles M; Soriano JB; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; Ancochea J;
Respir Res; 2010 May; 11(1):63. PubMed ID: 20500811
[TBL] [Abstract][Full Text] [Related]
19. Chronic rhinosinusitis is associated with higher prevalence and severity of bronchiectasis in patients with COPD.
Yang X; Xu Y; Jin J; Li R; Liu X; Sun Y
Int J Chron Obstruct Pulmon Dis; 2017; 12():655-662. PubMed ID: 28260873
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
